Skip to main content
Tango Therapeutics, Inc. (TNGX)
NASDAQ: TNGX · Real-Time Price · USD
25.14
-1.19 (-4.52%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Tango Therapeutics Revenue

In the year 2025, Tango Therapeutics had annual revenue of $62.38M with 48.29% growth.

Revenue (ttm)
$62.38M
Revenue Growth
+48.29%
P/S Ratio
58.13
Revenue / Employee
$455,358
Employees
137
Market Cap
3.63B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202562.38M20.32M48.29%
Dec 31, 202442.07M5.54M15.17%
Dec 31, 202336.53M11.67M46.93%
Dec 31, 202224.86M-12.18M-32.89%
Dec 31, 202137.04M29.39M383.83%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
ACADIA Pharmaceuticals 1.07B
Telix Pharmaceuticals 803.79M
Catalyst Pharmaceuticals 588.99M
Travere Therapeutics 490.73M
Arcus Biosciences 247.00M
NewAmsterdam Pharma Company 22.50M
Crinetics Pharmaceuticals 7.70M
Revenue Rankings

TNGX News

More News